Upgrade to SI Premium - Free Trial

bioAffinity (BIAF)

3.67 +0.01 (0.27%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Form 8-K bioAffinity Technologies For: Oct 15 October 15, 2026 9:30 AM - SEC Filing bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026 October 15, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Oct 13 October 13, 2026 9:23 AM - SEC Filing Form PRER14A bioAffinity Technologies October 13, 2026 6:10 AM - SEC Filing Form 8-K bioAffinity Technologies For: Oct 08 October 9, 2026 4:31 PM - SEC Filing bioAffinity Technologies closes $4M stock offering on Nasdaq October 9, 2026 12:30 PM - StreetInsider WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules October 9, 2026 12:30 PM - PR NewsWire Form 424B5 bioAffinity Technologies October 9, 2026 12:00 PM - SEC Filing bioAffinity Technologies closes $4 million stock offering October 9, 2026 11:37 AM - StreetInsider bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules October 9, 2026 11:37 AM - BizWire Form 424B5 bioAffinity Technologies October 9, 2026 11:26 AM - SEC Filing bioAffinity Technologies raises ~$4M in stock offering via WallachBeth October 8, 2026 1:30 PM - StreetInsider WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules October 8, 2026 1:30 PM - PR NewsWire bioAffinity Technologies plans $4M stock offering on Nasdaq October 8, 2026 12:07 PM - StreetInsider bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules October 8, 2026 12:07 PM - BizWire Form 8-K bioAffinity Technologies For: Oct 08 October 8, 2026 8:31 AM - SEC Filing bioAffinity Technologies receives Japanese patent notice for CyPath Lung October 8, 2026 8:01 AM - StreetInsider bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm October 8, 2026 8:00 AM - BizWire bioAffinity Technologies reports 100% sales growth for CyPath Lung test October 6, 2026 9:20 AM - StreetInsider bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026 October 6, 2026 9:19 AM - BizWire Form 8-K bioAffinity Technologies For: Oct 06 October 6, 2026 8:30 AM - SEC Filing Form 8-K bioAffinity Technologies For: Sep 30 September 30, 2026 8:30 AM - SEC Filing bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL September 30, 2026 8:00 AM - BizWire Form PRE 14A bioAffinity Technologies For: Sep 29 September 29, 2026 9:30 AM - SEC Filing Form 8-K bioAffinity Technologies For: Sep 22 September 22, 2026 8:31 AM - SEC Filing bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference September 22, 2026 8:00 AM - BizWire Four High-Impact Small Caps Enter the Spotlight September 17, 2026 11:38 AM - StreetInsider Form 8-K bioAffinity Technologies For: Sep 17 September 17, 2026 8:31 AM - SEC Filing bioAffinity Technologies receives Hong Kong patent for lung cancer test September 17, 2026 8:02 AM - StreetInsider bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic September 17, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Sep 11 September 11, 2026 8:31 AM - SEC Filing Four Biotech Stories Heating Up Right Now September 9, 2026 11:56 AM - StreetInsider BioAffinity regains Nasdaq compliance for stock and warrants September 9, 2026 8:08 AM - StreetInsider Form S-3 bioAffinity Technologies August 27, 2026 4:31 PM - SEC Filing Form 8-K bioAffinity Technologies For: Aug 20 August 20, 2026 8:31 AM - SEC Filing bioAffinity Technologies sets 1-for-15 reverse stock split Aug. 24 August 20, 2026 8:00 AM - StreetInsider bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 August 20, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Aug 18 August 18, 2026 8:31 AM - SEC Filing bioAffinity strikes federal distribution deal for CyPath Lung test August 18, 2026 8:01 AM - StreetInsider bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung August 18, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Aug 12 August 14, 2026 4:34 PM - SEC Filing bioAffinity Technologies closes $4M private placement via pre-funded warrants August 14, 2026 11:45 AM - StreetInsider WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 14, 2026 11:45 AM - PR NewsWire bioAffinity Technologies closes $4M private placement offering August 14, 2026 11:07 AM - StreetInsider bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 14, 2026 11:07 AM - BizWire bioAffinity Technologies prices $4M private placement on Nasdaq August 13, 2026 10:01 AM - StreetInsider WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 13, 2026 10:01 AM - PR NewsWire bioAffinity Technologies prices $4M private placement offering August 13, 2026 9:07 AM - StreetInsider bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 13, 2026 9:07 AM - BizWire Form 10-Q bioAffinity Technologies For: Jun 30 August 7, 2026 4:46 PM - SEC Filing bioAffinity (BIAF) Tops Q2 EPS by 146c August 7, 2026 8:51 AM - StreetInsider Form 8-K bioAffinity Technologies For: Aug 07 August 7, 2026 8:30 AM - SEC Filing bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung August 7, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Jul 30 July 31, 2026 5:15 PM - SEC Filing Form 8-K bioAffinity Technologies For: Jul 27 July 27, 2026 8:31 AM - SEC Filing bioAffinity publishes clinical framework for CyPath Lung nodule testing July 27, 2026 8:09 AM - StreetInsider bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung July 27, 2026 8:08 AM - BizWire Full Article List